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The Impact of PPP in Redox and Energy Conservation
The pentose-phosphate pathway (PPP) promotes the oxidative decarboxylation of glucose-6-
phosphate (G6P) in two consecutive steps, catalyzed by glucose-6-phosphate dehydrogenase
(G6PD) and 6-phosphogluconate dehydrogenase (6PGD), yielding ribulose-5-phosphate (Ru5P)
(Figure 1) (Wamelink et al., 2008). These steps constitute the so-called oxidative PPP branch,
where the redox energy of G6P is conserved as NADPH(H+). Together with other NADPH(H+)
regenerating systems, such as NADP-dependent isocitrate dehydrogenase and malic enzyme (ME),
the oxidative PPP branch represents the most important source of reducing equivalents for (i)
antioxidant enzymes, such as glutathione peroxidases and thioredoxin reductases, and (ii) fatty
acid synthase (Dringen et al., 2007). Ru5P is isomerized into ribose-5-phosphate (R5P), which
serves either as the precursor for nucleotide biosynthesis, or it continues metabolism through
the non-oxidative PPP branch. In the latter, R5P epimerize into xylulose-5-phosphate (Xu5P),
with which it transketolases producing sedoheptulose-7-phosphate (S7P) plus glyceraldehyde-3-
phosphate (G3P). In turn, S7P and G3P transaldolase to form fructose-6-phosphate (F6P) and
erythrose-4-phosphate (E4P). E4P is then transketolated with Xu5P forming F6P and G3P. Thus,
through the PPP, threemoles of G6P yield three CO2, two F6P, and one G3P. Since PPP-derived F6P
and G3P are glycolytic intermediates too, they can follow conversion into pyruvate. Thus, glycolysis
and PPP are two different pathways that share common pools of F6P and G3P intermediates.
Accordingly, G6P converted into pyruvate through the PPP conserves both the redox and the
energetic values of glucose, highlighting a yet unrecognized high impact of PPP flux activity in
redox/energy conservation.
Abbreviations: E4P, erythrose-4-phosphate; F6P, fructose-6-phosphate; F6B, fructose-1,6-bisphosphate; G3P, glyceraldehyde-
3-phosphate; G6P, glucose-6-phosphate; R5P, ribose-5-phosphate; G6PD, glucose-6-phosphate dehydrogenase; GSH,
glutathione, reduced form; GSSG, glutathione, oxidized form; F26BP, fructose-2,6-bisphosphate; ME, malic enzyme; PEPCK,
phosphoenolpyruvate carboxykinase; PFK1, 6-phosphofructo-1-kinase; PFKFB3, 6-phosphofructo-2-kinase/fructose-2,6-
bisphosphatase, isoform 3; PGI, phosphoglucose isomerase; 6PGD, 6-phosphogluconate dehydrogenase; PPP, pentose-
phosphate pathway; Ru5P, ribulose-5-phosphate; TCA, tricarboxylic acid; S7P, sedoheptulose-7-phosphate; Xu5P, xilulose-
5-phosphate.
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FIGURE 1 | 13C-Pyruvate labeling pattern from [2-13C]glucose by
recycling PPP underestimates PPP contribution to glucose
metabolism. Labeling pattern in 13C-pyruvate originated from glycolysis
([2-13C]pyruvate) differs from that originated from a first round of PPP
([3-13C]- and [1,3-13C2]pyruvate), thus helping to estimate the contribution
of both pathways in glucose utilization (blue carbons). However, some cell
types, such as neurons, express high PGI activity responsible for high
equilibration rate of F6P with G6P, hence leading to a recycling-like PPP
(PPP – second and third rounds). Identification of these recycling-PPP
13C-labeled intermediates (black carbons) identifies a more complex pattern
of 13C-pyruvate labeling ([1-13C]-, [2-13C]-, and [1,2-13C2]pyruvate after the
second PPP round; pattern after a third PPP round is omitted for simplicity)
that overestimates glycolysis, hence underestimating the contribution of PPP
to glucose utilization. Please note that [1-13C]pyruvate could also come from
TCA cycle (pyruvate re-recycling; see text). However, this formation
represents as low as one-twelfth of the pyruvate originated from the second
round of PPP, thus likely minimally affecting to PPP activity estimation.
Therefore, labeling in 13C-Ru5P and 13C-R5P ([2-13C]-, [1,2-13C2]-,
[1,2,3-13C3]-, etc.) after the second PPP round can be used for an accurate
estimation of PPP in highly recycling cells.
Radioactive PPP Assessment Ex Vivo
Several approaches have been used to estimate the fraction of
G6P that is metabolized through the PPP. For experiments
performed ex vivo (cultured and freshly isolated cells, or tissue
slices), radiometric 14CO2 detection after incubation of the
biological samples in the presence of [1-14C]glucose, under
initial velocity conditions, reports flux through the oxidative
branch of the PPP. However, since C1-G6P is also decarboxylated
in the tricarboxylic acid (TCA) cycle, the 14CO2-value, taken
alone, intrinsically over-estimates PPP activity. To overcome
this drawback, a parallel incubation under identical conditions
needs to be performed to quantify 14CO2 collected from [6-
14C]glucose, since C6-G6P is exclusively decarboxylated in the
TCA after G6P is converted into pyruvate both through glycolysis
and PPP. Thus, the difference in the rate of 14CO2 produced
from [1-14C]glucose and that from [6-14C]glucose represents the
flux of 14CO2 exclusively produced at the oxidative PPP branch
(Hothersall et al., 1979; Larrabee, 1989). Whilst this approach is
suitable for ex vivo analyses, it is technically tedious for in vivo
PPP assessments, as CO2 collection in vivo is hardly quantitative.
13C-NMR PPP Assessment In Vivo
Several approaches have been used to assess the proportion of
G6P that is metabolized through the PPP in vivo—which are
also useful for ex vivo. A widely used method is essentially
based on the analysis of 13C abundance of certain carbon-
atoms in lactate upon perfusion (in vivo) or incubation (ex
vivo) with [2-13C]glucose. Thus, the abundance of [3-13C]lactate
is assumed to be exclusively originated via PPP metabolism,
whereas the abundance of [2-13C]lactate, via glycolysis (Figure 1)
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(Brekke et al., 2012). In a slightly different approach based on
the use of [1,2-13C2]glucose, the abundances of [3-
13C]lactate
and [2,3-13C]lactate are considered to be originated via PPP
and glycolysis, respectively (Jalloh et al., 2015). [1,6-13C2,6,6-
2H2]glucose has also been used to measure cerebral PPP activity
in vivo (Ben-Yoseph et al., 1995) on the bases that it produces
[3-13C]lactate and [3-13C,3,3-2H2]lactate through glycolysis, but
[3-13C,3,3-2H2]lactate and unlabeled lactate through PPP (Ross
et al., 1994). The ratios of these lactate isotopomers can be
quantified using gas chromatography/mass spectrometry for
calculation of PPP activity, and expressed as the percentage of
glucose metabolized to lactate that passed through the PPP (Ross
et al., 1994; Ben-Yoseph et al., 1995). These analyses provide
information on the relative contribution of a metabolic pathway
within overall glucose utilization, in contrast to the initial velocity
analyses, which informs on absolute metabolic flux values.
Whilst such a difference might account for the controversies in
PPP activity values reported by different laboratories (Herrero-
Mendez et al., 2009; Brekke et al., 2012; Rodriguez-Rodriguez
et al., 2013), in our opinion there are some methodological
concerns, as explained below.
Occurrence of Recycling PPP
A critical point that is often overlooked is the occurrence of
G6P recycling from PPP-derived F6P. Thus, phosphoglucose
isomerase (PGI) is a near-equilibrium enzyme that has been
shown to be highly active at converting F6P into G6P in
certain cells and/or tissues, such as, e.g., neurons (Gaitonde
et al., 1989), which can re-enter the PPP (Figure 1). In such
recycling-like PPP, only the PPP-derived G3P fully escapes from
this cycle to be transformed into pyruvate trough glycolysis.
High recovery of G6P from PPP-derived F6P may represent a
bioenergetics advantage, since the redox energy of glucose can
be conserved as NADPH(H+) at the expense of only one carbon
(C1) per G6P. It should be noted that, in certain cells such as
neurons, 6-phosphofructo-1-kinase (PFK1, which converts F6P
into fructose-1,6-bisphosphate or F16BP) represents a glycolysis
bottleneck (Almeida et al., 2004). Thus, PFK1 in situ activity
is very low in neurons when compared, e.g., with neighbor
astrocytes (Almeida et al., 2004). Such a low PFK1 activity is
due to the virtual absence of 6-phosphofructo-2-kinase/fructose-
2,6-bisphosphatase-3 (PFKFB3) (Herrero-Mendez et al., 2009),
responsible for the formation of fructose-2,6-bisphosphate
(F26BP)—the most potent positive PFK1 effector. In contrast,
astrocytes abundantly express PFKFB3 protein—and F26BP
concentration—and, accordingly, a high in situ PFK1 activity
(Almeida et al., 2004). It is therefore likely that, whereas PPP-
derived F6P is preferentially recycled in the PPP in neurons, it
is preferably converted into lactate in astrocytes. In fact, the in
situ PFK1 activity is∼four-fold lower in neurons when compared
with astrocytes (Almeida et al., 2004). Therefore, we hypothesize
that, in neurons, (i) most PPP-derived F6P is recycled back into
the PPP, and (ii) the vast majority of G3P pool is originated
directly from PPP activity. However, in astrocytes, G3P pool
is originated from (i) G6P through glycolysis, (ii) PPP-derived
F6P then via glycolysis, and (iii) directly from PPP activity. On
our opinion, these considerations may have implications when
interpreting the 13C-labeling data for the estimation of PPP
activity, as indicated below.
PPP Assessment is Intrinsically
Underestimated
When [2-13C]glucose infusion and/or incubation is used, [1-
13C]- and [1,3-13C2]lactate abundances are exclusively PPP-
derived, whereas [2-13C]lactate abundance is glycolysis-derived
(Figure 1). Therefore, the relative abundance of [1-13C]- and
[1,3-13C2]lactate when compared with total lactate is often
considered to be the proportion of glucose metabolized through
the PPP (Brekke et al., 2012). However, [1,3-13C2]F6P, formed
in the PPP from [2-13C]glucose, when converted into [1,3-
13C2]G6P via PGI activity (F6P−→G6P-forming), which is very
high in neurons (Gaitonde et al., 1989), can produce [2-13C]F6P
in the second PPP round (Figure 1). Thus, as from the second
PPP round and thereafter, such [2-13C]F6P will also yield [2-
13C]lactate, largely over-estimating glycolysis. In addition, the
degree of recycling PPP activity is not addressed when measuring
[3-13C,3,3-2H2]lactate plus unlabeled lactate that is formed from
[1,6-13C2,6,6-
2H2]glucose (Ben-Yoseph et al., 1995), since this
approach does not address the proportion of, and rate at which
F6P is recycled back into the PPP. It may therefore be concluded
that the methodological approaches to estimate recycling PPP
activity may be intrinsically underestimated in neurons. We
hypothesize that the degree of recycling PPP activity would
be best indicated by the levels of PPP-specific intermediates
(Figure 1). In view that [1,2-13C2]Ru5P is exclusively formed
by recycling PPP from [2-13C]glucose when entering the third
round, and [1,2,3-13C3]Ru5P when entering the fourth round, we
propose to determine the relative abundance of mono-labeled vs.
multiple labeled 13C-R5P +13C-Ru5P, which is feasible by liquid
chromatography/mass spectroscopy (LC/MS).
Overestimation of Glycolysis
It is a widely held custom to determine total lactate released
from cells as an index of glycolysis. However, given that—at
least under several circumstances—the precise proportion of G6P
that is metabolized through PPP to lactate is uncertain, total
lactate as an index of glycolysis should be taken with caution.
We rather propose that lactate release should be considered
as an overall index for glucose utilization—i.e., glycolysis plus
PPP. To estimate glycolysis, the use of [5-3H]glucose conversion
into 3H2O, which takes place at enolase, is often used to
assess the rate of glycolysis (Neely et al., 1972). However, since
enolase cannot distinguish the origin—glycolysis or PPP—of its
substrate—2-phosphoglycerate—, the production of 3H2O from
[5-3H]glucose does not help to clarify the specific contribution of
glycolysis to glucose utilization. Thus, the use of [5-3H]glucose
could greatly overestimate the rate of glycolysis in neurons,
as it has been shown in the rat heart (Goodwin et al., 2001),
which in turn underestimates PPP. We encourage the use of
[3-3H]glucose to estimate glycolysis, since 3H of C3-glucose
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interchanges with water at aldolase (Katz et al., 1965), hence
reducing the contribution of PPP to the collected 3H2O. Since
PFK1 in situ activity is very low in neurons (Herrero-Mendez
et al., 2009), the [3-3H]glucose approach reflects more accurately
glycolysis than the [5-3H]glucose one. Using [3-3H]glucose, we
have reported that primary cortical neurons produce 3H2O at a
rate that is ∼four-fold lower than in primary cortical astrocytes
(Almeida et al., 2004). However, the proportion of glucose that is
metabolized through glycolysis in neurons can be overestimated.
It has been widely reported that [1-13C]glucose perfusion in
rodents renders, in the brain, a higher 13C-specific enrichment in
[4-13C]glutamate (mainly present in neurons) compared to [4-
13C]glutamine (mainly present in astrocytes) (Fitzpatrick et al.,
1990; Kanamatsu and Tsukada, 1994; Bouzier et al., 1999). When
comparing the specific enrichment of [4-13C]glutamate and [1-
13C]glucose, it was calculated that∼90% of the [4-13C]glutamate
was originated from the glycolytic metabolism of [1-13C]glucose.
The ∼10% loss in specific enrichment of [4-13C]glutamate is
usually attributed to a loss of 13C1 in the PPP. Unfortunately, this
interpretation does not take into account that [3-13C]lactate can
be actively used by neurons and converted into [4-13C]glutamate
in vivo (Bouzier et al., 2000), since glycolytically-generated lactate
is shuttled from astrocytes to neurons (Pellerin and Magistretti,
1994; Bouzier-Sore et al., 2006), therefore underestimating in vivo
neuronal PPP.
Pyruvate Re-Cycling
Pyruvate can be re-generated from the TCA cycle intermediates
malate and oxaloacetate through ME and PEPCK, respectively.
Such a pyruvate re-cycling has been shown to occur in neurons
(Cerdan et al., 1990; Cruz et al., 1998), where malic enzyme is
expressed profusely (Vogel et al., 1998; McKenna et al., 2000),
although its occurrence in astrocytes has also been proposed
(Olstad et al., 2007). Therefore, when using [2-13C]glucose to
estimate the PPP activity, [2-13C]pyruvate entering the TCA
cycle will yield [1-13C]pyruvate from re-cycling, which will be
undistinguishable from that returning from the second PPP
round (Figure 1). This further reinforces our proposal that
PPP should be estimated by measuring 13C incorporation
into the five carbon-atom sugars, instead of that into lactate
or pyruvate.
PPP is an Advantage for Neurons that May
Failure in Neurodegeneration and Aging
Neurons are deficient in antioxidant glutathione (Bolaños et al.,
1995), hence recycling of reduced glutathione (GSH) from
its oxidized form (GSSG) is critical for their survival. Since
NADPH(H+) is essential for this process, the re-cycling version
of the PPP—which recovers a considerable proportion of G6P—
explains both the low glucose consumption and the efficient
GSH regenerating activity of neurons. In contrast, astrocytes
express higher PPP-rate limiting step G6PD, and PPP activity,
than neurons (Garcia-Nogales et al., 2003; Herrero-Mendez et al.,
2009), besides higher glycolysis (Almeida et al., 2004; Herrero-
Mendez et al., 2009). This is likely indicating that both non-
recycling PPP plus glycolysis contribute to glucose consumption
in astrocytes. Accordingly, G6P recovery through re-cycling PPP
in neurons represents an advantage for neuronal survival. A large
body of evidence is now showing, by PET studies, decreased
glucose consumption—actually reflecting glucose uptake—in the
human brain during aging and neurodegeneration (Chen and
Zhong, 2013). This observation has been widely interpreted
as a putative cause of limited energy production in neurons.
However, before we uncover the actual contribution of PPP to
glucose consumption by the brain cells, particularly neurons
and astrocytes, such an assertion remains uncertain. We
herein opine that the decrease in glucose utilization occurring
in aging and neurodegeneration, far from merely causing a
bioenergetics problem, would be responsible for an oxidative
damage due to failed PPP-derived NADPH(H+) regeneration
in neurons. Furthermore, we also propose that the impaired
glucose utilization observed in PET studies in neurodegeneration
and aging reflects, mainly, reduced glucose consumption in
astrocytes. This will, in turn, result in reduced lactate released
for neuronal conversion into either energy or neurotransmitter
glutamate. Either hypothesis, i.e., low neuronal PPP activity
causing failed antioxidant capacity, low lactate supply by
astrocytes, or a combination of both, may have been largely
overlooked as the cause of both bioenergetics and antioxidant
neuronal damage during aging and neurodegeneration. More in-
depth studies to overcome the methodological drawbacks herein
highlighted should be undertaken in order to unveil the actual
contribution of PPP to neuronal survival in vivo.
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